We examined the correlations between MYCN status, MYCN expression, and PHGDH expression in 94 samples with high-risk neuroblastoma, in the TARGET cohort; the expression of the genes in all samples was examined, that is, for cases with and without 11q LOH (Fig. 3D). The gene discussed is PHGDH; the disease is neuroblastoma.